We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Digital Pathology Market: Growth, Size, Share, and Trends

Report Code HIT 2608
Published in May, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030

 

Overview

The global digital pathology market, valued at US$1.30 billion in 2024, stood at US$1.46 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.75 billion by the end of the period. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics.

Collaborations have compelled the market, which is one of the key factors in play. In March 2024, Amazon Web Services (AWS) (US) and Koninklijke Philips (Netherlands) collaborated to provide cloud-based digital pathology solutions. The intent behind the collaboration was to enhance care delivery by boosting workflow efficiency, improving data security, and facilitating smooth integration with existing healthcare IT infrastructure.

As digital pathology becomes more widely adopted, healthcare organizations are increasingly drawing insights from early implementers to guide their own strategies. However, the market still faces challenges such as a shortage of trained pathologists, high initial investment requirements, and uncertainty around reimbursement policies, which may hinder widespread deployment in some regions.

Digital pathology Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Digital pathology Market

Asia Pacific

The Asia Pacific market is expected to grow at the highest rate during the forecast period, owing to the rising adoption of digital pathology and the expansion of its wide applications.

The demand for digital pathology solutions is primarily driven by the rising prevalence of cancer and growing applications in drug development and companion diagnostics.

Product launches, upgrades & approvals, and partnerships would offer lucrative opportunities for market players in the next 5 years.

The market growth in North America can be attributed to the well-developed research infrastructure and the presence of key players.

The growth opportunities in emerging markets and growing applications of imaging technology offer several opportunities for market growth.

Global Digital pathology Market Dynamics

DRIVER: Growing adoption of AI-enabled digital pathology

AI-enabled digital pathology is transforming laboratory throughput, giving automating burdensome tasks such as slide review, case anomaly detection, and image quantification. With AI algorithms cutting whole-slide image analysis time down by as much as 60% compared to the time it takes to manually analyze slides, pathologists can get through more cases in less time. In a 2020 article published in JAMA Network Open, investigators found the AI-assisted diagnostic model increased pathologist efficiency by over 20% without impacting diagnostic accuracy, and there is significant opportunity for cost, time, and efficiency improvements across the continuum of care. AI-enabled digital pathology applications that integrate with Laboratory Information Systems (LIS) allow real-time data sharing and collaboration to improve workflow and laboratory turnaround times, decreasing instances of human error. Accordingly, laboratories implementing AI through digital pathology solutions are experiencing increases in daily case volumes, enhanced diagnostic consistency, and more optimal overall case management.

RESTRAINT: High initial capital costs

The major hurdle for labs realizing a digital pathology process is the high upfront costs for systems, including whole-slide scanners, image management software, storage infrastructure, and AI analytics tooling. A whole-slide scanner alone can run between USD 50,000 and USD 300,000 or more, depending on throughput and features. Additionally, labs must invest in IT infrastructure, data security, and staff training resources to ensure proper implementation and reliability of digital processes; all this can easily add up to the utilization factor, which minimizes or eliminates any up-front costs. These expenses can slow the digital transition process for smaller labs or labs without adequate resource support, despite the streamlined efficiency and diagnostic advantages realized over time.

 

OPPORTUNITY: Government-backed digitization in emerging economies

Government-led initiatives for digitization in developing countries serve as an incubator for making digital pathology widespread with improved healthcare infrastructure for rural and underserved areas and increased acceptance and integration of technology. India (Ayushman Bharat Digital Mission), Brazil (Conecte SUS), and South Africa invest in digital health ecosystems to expand health quality and accessibility, enhance interoperability, and provide rapid, accurate diagnostics. Each program or initiative may provide funding or guidance in creating a digitized laboratory, supporting telepathology, and actionable intelligence through an AI diagnosis. These efforts will initiate a solid pathway for emerging economies to provide digital pathology that corrects existing infrastructure and greater adoption of a digital record system in rural or underserved areas, specifically in the public sector.

CHALLENGES: Algorithm validation issues

Algorithm validation and building trust with clinicians is an important challenge for AI-based digital pathology. AI models need to be validated and published as required, especially in diverse populations with different tissue types and staining variations, to gain the reliability and accuracy needed in a clinical setting. However, many algorithms will be trained on a relatively small population or homogenous data, raising questions about bias, reproducibility, routine practice, or generalizability. Furthermore, some AI systems are characterized as a black box that is opaque to pathologists when looking to interpret and understand how decisions are made, which can slow adoption into a clinical setting. Regulatory governing bodies like the FDA and CE increasingly require transparency, explainability, and performance in real-world settings; however, establishing widespread clinical comfort and trust in AI will require transparency and validation, peer-reviewed evidence, and demonstrable performance in the routine practice environment.

Global Digital pathology Market Ecosystem Analysis

The ecosystem of the digital pathology market comprises entities responsible for delivering digital pathology solutions to end users via various deployment models. The demand continues to grow and expand as enterprises implement digital pathology software to reduce costs and optimize the workload performance of their health systems. Solution and service providers continue to enhance and mature their offerings to increase the value addition.

Solution providers in the digital pathology market develop high-end digital pathology solutions based on the customer’s requirements.

Digital pathology Market Ecosystem
 

The global Digital pathology market is segmented by product, type, application, end user, and region. By product, the software segment dominated the digital pathology market in 2024.

The software segment was the highest CAGR segment of the digital pathology market in 2024. This can be attributed, in part, to the addition of AI and machine learning components, which improve the analysis of digital pathology images. By using AI-powered tools, pathologists can identify the subtle patterns that will lead to an improved, more accurate pathology diagnosis and better utilization of the pathologist's time and effort. On top of that, software is required to integrate with other health IT solutions, such as EHRs or LIS, that enable automated workflows, better data accessibility, and ease of collaboration between pathology and other clinical and surgical services. As digital workflows become the norm, the expectation of advanced analytics and analytics interoperability tools will rise.

The drug discovery segment accounted for the largest share of the global digital pathology market in 2024.

In the market for digital pathology, the drug discovery segment held the most share in 2024 as there was an increasingly important need to speed up and advance timelines for drug development. Digital pathology allows for an effective analysis of the larger datasets generated from images of tissue sections at significantly lower costs, which leads to better early-stage research decisions.

In the area of drug discovery, artificial intelligence contributes to drug discoveries by predicting protein structures and simulating interactions of compounds before synthesis, increasing the safety and rate at which drug contenders are evaluated. Digital pathology also promotes the ability for global research teams to seamlessly share real-time data, forging collaboration, cooperation, and innovation.

There are also surging R&D investments, government funding, and higher amounts of work in the life sciences and nanoscale science research areas. This demonstrates how digital pathology continues to grow in the drug discovery segment.

North America led the global digital pathology market in 2024.

The digital pathology market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of the Digital Pathology market. This is due to its advanced healthcare infrastructure and significant investment in healthcare technologies. North America, particularly the US, has a high prevalence of cancer, driving the demand for efficient and accurate diagnostic tools.

HIGHEST CAGR MARKET (2025–2030)
CHINA FASTEST GROWING MARKET IN THE REGION
Digital pathology Market Region

Recent Developments of Digital pathology Market

  • In March 2024, Koninklijke Philips N.V. (Netherlands) announced an expanded collaboration with AWS to address the growing need for secure, scalable digital pathology solutions in the cloud. This collaboration will help accelerate workflow efficacy and enable seamless integration with the existing healthcare system to deliver holistic patient care.
  • In February 2024, Roche announced its collaboration with Path AI to develop an AI-enabled digital pathology algorithm in the companion diagnostics space. This collaboration will allow Roche to accelerate its ability to meet the demand from biopharma companies looking to develop AI-enabled companion diagnostics and provide end-to-end solutions.
  • In March 2022, Roche Diagnostics partnered with SRL Diagnostics. Under this partnership, SRL Diagnostics planned to transform its lab at Fortis Memorial Research Institute with Roche Diagnostics.
  • In March 2023, Agilent Technologies partnered with Hamamatsu Photonics K.K. to incorporate the NanoZoomer range, including the S360MD Slide scanner system, into its end-to-end digital pathology solution.

Key Market Players

Want to explore hidden markets that can drive new revenue in Digital Pathology Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Million/Billion (USD)
Segments covered Product, Type, Application, and End User
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Frequently Asked Questions (FAQ)

Which are the top industry players in the digital pathology market?

Prominent players include Fujifilm Holdings Corporation (Japan), Danaher Corporation (US), Koninklijke Philips N.V. (Netherlands), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Glencoe Software, Inc. (US), Aiforia (Finland), Paige AI, Inc. (US), Huron Digital Pathology (Canada), Hologic, Inc. (US), Corista (US), Mikroscan Technologies, Inc. (US), PathAI (US), Hamamatsu Photonics K.K. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Proscia Inc. (US), Indica Labs Inc. (US), Objective Pathology Services Limited (Canada), Sectra AB (Sweden), OptraSCAN (US), Akoya Biosciences, Inc. (US), Motic Digital Pathology (US), and Kanteron Systems (Spain).

Which type has been included in the digital pathology market report?

Human Pathology and Veterinary Pathology.

Which geographical region is dominating in the digital pathology market?

North America is expected to hold the largest market share. The Asia Pacific region is projected to register the highest growth during the forecast period.

Which end-user segments have been included in the digital pathology market report?

Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Labs, and Academic & Research Institutes.

What is the total CAGR expected to be recorded for the digital pathology market during the forecast period?

The market is expected to record a CAGR of 13.5% from 2025 to 2030.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Digital Pathology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
12
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
54
PREMIUM INSIGHTS
76
MARKET OVERVIEW
87
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    MAJOR DRIVERS
    KEY RESTRAINTS
    KEY GROWTH OPPORTUNITIES
    INDUSTRY-SPECIFIC CHALLENGES
  • 5.3 REGULATORY LANDSCAPE (AS OF 2025)
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS/MARKET MAP
  • 5.7 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    COMPLEMENTARY TECHNOLOGIES
    ADJACENT TECHNOLOGIES
  • 5.8 PORTER’S FIVE FORCE ANALYSIS
  • 5.9 TRADE ANALYSIS
  • 5.10 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF PRODUCT TYPE, BY KEY PLAYERS 2022-2024
    AVERAGE SELLING PRICE TREND OF PRODUCT TYPE, BY REGION 2022-2024
  • 5.11 KEY CONFERENCES AND EVENTS IN 2025-2026
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN THE BUYING PROCESS
    BUYING CRITERIA
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.14 UNMET NEEDS AND KEY PAIN POINTS
  • 5.15 INVESTMENT AND FUNDING SCENARIO
  • 5.16 IMPACT OF GEN AI ON DIGITAL PATHOLOGY MARKET
DIGITAL PATHOLOGY MARKET, BY PRODUCT (USD MILLION; 2022—2030)
116
  • 6.1 INTRODUCTION
  • 6.2 SCANNERS
    BRIGHTFIELD SCANNERS
    FLUROSCENCE SCANNERS
    OTHER SCANNERS
  • 6.3 SOFTWARE
    SOFTWARE BY TYPE
    - INTEGRATED SOFTWARE
    - STANDALONE SOFTWARE
    - IMAGE MANAGEMENT SOFTWARE
    - IMAGE ANALYSIS/AI SOFTWARE
    SOFTWARE BY DEPLOYMENT MODE
    - ON PREMISE
    - CLOUD-BASED
    - HYBRID
  • 6.4 STORAGE SYSTEMS
DIGITAL PATHOLOGY MARKET, BY APPLICATION (USD MILLION; 2022—2030)
167
  • 7.1 INTRODUCTION
  • 7.2 DRUG DISCOVERY
  • 7.3 DISEASE DIAGNOSIS
  • 7.4 TRAINING & EDUCATION
DIGITAL PATHOLOGY MARKET, BY TYPE (USD MILLION; 2022—2030)
187
  • 8.1 INTRODUCTION
  • 8.2 HUMAN PATHOLOGY
  • 8.3 VETERINARY PATHOLOGY
DIGITAL PATHOLOGY MARKET, BY END USER (USD MILLION; 2022—2030)
207
  • 9.1 INTRODUCTION
  • 9.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 9.3 HOSPITAL & REFERENCE LABORATORIES
  • 9.4 RESEARCH & ACADEMIC INSTITUTES
  • 9.5 VETERINARY LABORATORIES
DIGITAL PATHOLOGY MARKET, BY REGION (USD MILLION; 2022—2030)
255
  • 10.1 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    CANADA
  • 10.2 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    UK
    FRANCE
    ITALY
    SWITZERLAND
    NETHERLANDS
    REST OF EUROPE (ROE)
  • 10.3 ASIA-PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    CHINA
    INDIA
    SOUTH KOREA
    AUSTRALIA
    REST OF ASIA-PACIFIC (ROAPAC)
  • 10.4 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA (ROLA)
  • 10.5 MIDDLE EAST AND AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC REGION
    REST OF MIDDLE EAST AND AFRICA (ROMEA)
COMPETITIVE LANDSCAPE
286
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2022-2025)
  • 11.3 REVENUE SHARE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS BY TOP 5 PLAYERS (% REVENUE, 2024)
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - PRODUCT FOOTPRINT
    - APPLICATION FOOTPRINT
    - END-USER FOOTPRINT
    - REGIONAL FOORPRINT
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SME, 2024
  • 11.7 COMPETITIVE SCENARIO AND TRENDS (2022-2025)
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
    OTHER DEVELOPMENTS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPANY VALUATION AND FINANCIAL METRICS
COMPANY PROFILES
302
  • 12.1 KEY PLAYERS
    DANAHER CORPORATION
    KONINKLIJKE PHILIPS N.V.
    HAMAMATSU PHOTONICS
    F. HOFFMANN-LA ROCHE LTD.
    SECTRA AB
    3DHISTECH
    APOLLO ENTERPRISE IMAGING CORP.
    XIFIN, INC.
    HURON DIGITAL PATHOLOGY
    PAIGE AI, INC.
    CORISTA
    INDICA LABS INC.
    OBJECTIVE PATHOLOGY SERVICES LIMITED
    OPTRASCAN, INC.
    GLENCOE SOFTWARE, INC.
    HOLOGIC INC.
    PROSCIA INC.
  • 12.2 FUJIFILM HOLDINGS CORPORATION
    ALFORIA TECHNOLOGIES OYJ
FUJIFILM HOLDINGS CORPORATION
323
AKOYA BIOSCIENCES, INC.
  • 13.1 OTHER PLAYERS
    KONFOONG BIOTECH INTERNATIONAL CO., LTD.
    PATHAI, INC.
    MIKROSCAN TECHNOLOGIES, INC.
    MOTIC DIGITAL PATHOLOGY
    KANTERON SYSTEMS
APPENDIX
355

 

The study involved five major activities to estimate the current size of the digital pathology market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

The market for the companies offering digital pathology solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of digital pathology vendors, forums, certified publications, and white papers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global Digital Pathology market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital Directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Digital pathology Market

Note 1: Other designations include sales managers, marketing managers, and product managers.

Note 2: Tiers of companies are defined on the basis of their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the Digital Pathology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Digital pathology Market

Data Triangulation

After arriving at the overall market size, using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides in the Digital Pathology Market.

Market Definition

Digital pathology refers to the use of digital technology to capture, manage, share, and analyze pathology information, typically in the form of high-resolution digital images derived from glass slides. This technology allows pathologists to view, interpret, and manage pathology data more efficiently and accurately.

Stakeholders

  • Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Pharmacies, Ambulatory Centers, and Outpatient Clinics)
  • Digital Pathology Organizations
  • Senior Management
  • Finance/Procurement Department
  • R&D Department
  • Healthcare Data Aggregators
  • Venture Capitalists
  • Government Agencies
  • Healthcare Startups, Consultants, and Regulators
  • Academic Medical Institutes

Report Objectives

  • To define, describe, and forecast the global digital pathology market based on product, type, application, end user, and region
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets concerning individual growth trends, prospects, and contributions to the overall digital pathology market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically analyze the market structure, profile the key players of the digital pathology market, and comprehensively analyze their core competencies
  • To forecast the size of the market segments for five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments such as product launches & enhancements, investments, partnerships, collaborations, acquisitions, expansions, agreements, sales contracts, and alliances in the digital pathology market during the forecast period

 

Previous Versions of this Report

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals) & Region - Global Forecast to 2026

Report Code HIT 2608
Published in Jun, 2023, By MarketsandMarkets™

Digital Pathology Market by Product( ArtificiaI Intelligence, Scanner, Software, Storage), Type(Human, Veterinary), Application( Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User( Pharma, Academia, Hospitals ) - Global Forecast to 2026

Report Code HIT 2608
Published in Mar, 2022, By MarketsandMarkets™

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025

Report Code HIT 2608
Published in Oct, 2020, By MarketsandMarkets™

Digital Pathology Market by Application (Disease Diagnosis, Drug Discovery, Teleconsultation), Product (Scanner, Software, Communication System), Type (Human, Veterinary), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022

Report Code HIT 2608
Published in Mar, 2020, By MarketsandMarkets™

Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022

Report Code HIT 2608
Published in Oct, 2017, By MarketsandMarkets™

Digital Pathology Market by Product (Scanners, Software), by Type (Human, Animal Pathology), by End User (Pharmaceutical Company, Hospital, Academic Institutions), by Application (Teleconsultation, Drug Discovery) - Global Forecasts to 2021

Report Code HIT 2608
Published in May, 2016, By MarketsandMarkets™

Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

Report Code HIT 2608
Published in Aug, 2014, By MarketsandMarkets™

Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2029

Report Code HIT 2608
Published in May, 2025, By MarketsandMarkets™

Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

Report Code HIT 2608
Published in Jan, 2011, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Digital Pathology Market

Jamie

Jul, 2022

Keen to Know about Digital Pathology Market Size, Share and Trend Analysis Report by Product (ArtificiaI Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), and Pharma, Diagnostic Labs, Hospitals as well as Academia, Hospitals - Global Forecast to 2031.

Jason

Mar, 2022

Looking to gain more insights on the global Industrial Digital Pathology Market.

Jeffrey

Mar, 2022

What are the growth opportunities in Digital Pathology Market?.

Jeffrey

Mar, 2022

What are the growth opportunities in Digital Pathology Market?.

Ryan

Mar, 2022

Can you enlighten us on geographical growth analysis in Digital Pathology Market?.

DMCA.com Protection Status